Kostine, M., Finckh, A., Bingham, C. O., Visser, K., Leipe, J., Schulze-Koops, H., . . . Schaeverbeke, T. (2021). EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Annals of the rheumatic diseases, 80(1), . https://doi.org/10.1136/annrheumdis-2020-217139
Chicago-Zitierstil (17. Ausg.)Kostine, Marie, et al. "EULAR Points to Consider for the Diagnosis and Management of Rheumatic Immune-related Adverse Events Due to Cancer Immunotherapy with Checkpoint Inhibitors." Annals of the Rheumatic Diseases 80, no. 1 (2021). https://doi.org/10.1136/annrheumdis-2020-217139.
MLA-Zitierstil (9. Ausg.)Kostine, Marie, et al. "EULAR Points to Consider for the Diagnosis and Management of Rheumatic Immune-related Adverse Events Due to Cancer Immunotherapy with Checkpoint Inhibitors." Annals of the Rheumatic Diseases, vol. 80, no. 1, 2021, https://doi.org/10.1136/annrheumdis-2020-217139.